Organon & Co | OGN - رأس المال والاحتياطيات





رأس المال والاحتياطيات تغيير تاريخ
Bristol-Myers Squibb USD 20.07B 1.6B 2026-03
Celltrion KRW 434.82B 1.14B 2026-03
Cspc Pharmaceutical CNY 33.18B 71.46M 2025-12
Deva Holding AS TRY 5.79B 604.07M 2023-09
Dianthus Therapeutics USD 1.2B 707.91M 2026-03
Divis Laboratories Ltd INR 167.61B 13.48B 2026-03
Gilead Sciences USD 23.52B 897M 2026-03
Glaxosmithkline GBP 17.42B 4.64B 2026-03
Kangmei Pharma CNY 7.31B 84.82M 2026-03
Knight Therapeutics CAD 767.27M 480K 2025-12
Laboratorios Farma EUR 539.39M 22.74M 2023-12
Malin Corporation EUR 193.2M 75M 2024-12
Medical Developments International AUD 54.77M 335K 2025-12
Merck USD 45.88B 6.73B 2026-03
Neuren Pharmaceuticals AUD 338.45M 15.18M 2025-12
Novartis USD 38.93B 7.2B 2026-03
Organigram Holdings CAD 371.81M 2.36M 2026-03
Organon & Co USD 903M 151M 2026-03
Ovoca Bio EUR 1.26M 7.41M 2025-06
Pharma Mar EUR 249.67M 2.16M 2026-03
Qiagen NV USD 3.78B 128.73M 2025-12
Sartorius EUR 2.73B 1.14B 2026-03
Sino Biopharmaceutical CNY 34B 1.48B 2025-06
Tilray USD 1.58B 39.08M 2025-09
Zealand Pharma A/S 14.83B 331.99M 2025-12